» Articles » PMID: 39599487

Infection-Associated Flares in Systemic Lupus Erythematosus

Overview
Journal Pathogens
Date 2024 Nov 27
PMID 39599487
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is characterised by generalised immune dysfunction, including infection susceptibility. Infection-associated flares (IAFs) are common and might rapidly self-resolve, paralleling infection resolution, but their specific clinical phenotype is poorly understood. Therefore, we screened 2039 consecutive visits and identified 134 flares, defined as a loss of the lupus low disease activity state (LLDAS), from 1089 visits at risk spanning over multiple follow-up years, yielding an average yearly LLDAS deterioration rate of 17%. Thirty-eight IAFs were isolated from the total flares and were mostly related to bacterial and herpesvirus infections. When compared to other flares (OFs; n = 98), IAFs showed no milder patterns of organ involvement and similar rates of long-term damage accrual, as estimated by conventional clinimetrics. Arthritis in IAFs was more severe than that in OFs [median (interquartile range) DAS-28 2.6 (2.3-4.1) vs. 2.0 (1.6-2.7); = 0.02]. Viral IAFs were characterised by atypically lower levels of anti-DNA antibodies ( < 0.001) and possibly abnormally high complement levels when compared to flares of different origin. These data suggest that IAFs are of comparable or even higher severity than OFs and may subtend distinct pathophysiological mechanisms that are poorly tackled by current treatments. Further research is needed to confirm these data.

References
1.
Vieira de Rezende R, Mattos G, de Mello Leal Augusto R, Machado Gayer C, Mendes Klumb E . Predictors for seasonal influenza vaccination and reasons for inadequate vaccination coverage against a broad spectrum of vaccine-preventable diseases: a cross-sectional study among a Brazilian cohort of adult patients with systemic lupus.... Lupus. 2019; 28(6):794-796. DOI: 10.1177/0961203319846383. View

2.
Ramirez G, Canti V, Moiola L, Magnoni M, Rovere-Querini P, Coletto L . Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study. Int J Rheum Dis. 2019; 22(9):1752-1761. DOI: 10.1111/1756-185X.13663. View

3.
Wu S, Perry A, Zimmerman N, Bryant G . Predictors of flare-related inpatient or emergency department stay in systemic lupus erythematosus: A real-world analysis of Medicaid claims in the United States. J Manag Care Spec Pharm. 2023; 30(1):61-70. PMC: 10775771. DOI: 10.18553/jmcp.2024.30.1.61. View

4.
Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A . Long COVID science, research and policy. Nat Med. 2024; 30(8):2148-2164. DOI: 10.1038/s41591-024-03173-6. View

5.
Touma Z, Gladman D, Urowitz M . Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign. Curr Opin Rheumatol. 2013; 25(2):164-70. DOI: 10.1097/BOR.0b013e32835d2b7b. View